Showing results (271-280 of 596) with videos related to
Sort By:
Pageof 60
Circulation|October 7, 1997
Passive cigarette smoking and reduced HDL cholesterol levels in children with high-risk lipid profilesE J Neufeld, M Mietus-Snyder, A S Beiser, et al.Journal of Medical Economics|April 24, 2018
Cost analysis of plasma-derived factor VIII/von Willebrand factor versus recombinant factor VIII for treatment of previously untreated patients with severe hemophilia A in the United StatesEllis J Neufeld, Robert F Sidonio, Ken O'Day, et al.Psychological Assessment|June 3, 2009
Assessing traumatic event exposure: comparing the Traumatic Life Events Questionnaire to the Structured Clinical Interview for DSM-IVJessica M Peirce, Christopher K Burke, Kenneth B Stoller, et al.Environmental Monitoring and Assessment|March 18, 2019
Interplay of phosphorus doses, cyanobacterial inoculation, and elevated carbon dioxide on yield and phosphorus dynamics in cowpeaSumit Kumar Dey, B Chakrabarti, T J Purakayastha, et al.Social Cognitive and Affective Neuroscience|February 21, 2018
Greater involvement of action simulation mechanisms in emotional vs cognitive empathyLindsay D Oliver, Joana B Vieira, Richard W J Neufeld, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 1, 2005
Sustained interferon-gamma delivery from a photocrosslinked biodegradable elastomerFrank Gu, Husam M Younes, Ayman O S El-Kadi, et al.Journal of Blood Medicine|October 13, 2022
Gene Therapy and Hemophilia: Where Do We Go from Here?Nancy S Bolous, Nidhi Bhatt, Nickhill Bhakta, et al.Social Cognitive and Affective Neuroscience|October 25, 2011
Do fearful eyes activate empathy-related brain regions in individuals with callous traits?Thida Han, Gésine L Alders, Steven G Greening, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|December 21, 2013
Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 μg kg⁻¹) rFVIIa doses across clinical trials and registriesA D Shapiro, E J Neufeld, V Blanchette, et al.The Journal of Pediatrics|December 3, 2014
Pediatric heparin-induced thrombocytopenia: prevalence, thrombotic risk, and application of the 4Ts scoring systemEsther A Obeng, Kathy M Harney, Thomas Moniz, et al.Pageof 60